1. Home
  2. IMAB vs CCSI Comparison

IMAB vs CCSI Comparison

Compare IMAB & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • CCSI
  • Stock Information
  • Founded
  • IMAB 2014
  • CCSI 2021
  • Country
  • IMAB United States
  • CCSI United States
  • Employees
  • IMAB N/A
  • CCSI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • CCSI Retail: Computer Software & Peripheral Equipment
  • Sector
  • IMAB Health Care
  • CCSI Technology
  • Exchange
  • IMAB Nasdaq
  • CCSI Nasdaq
  • Market Cap
  • IMAB 486.4M
  • CCSI 549.8M
  • IPO Year
  • IMAB 2020
  • CCSI N/A
  • Fundamental
  • Price
  • IMAB $4.70
  • CCSI $27.37
  • Analyst Decision
  • IMAB Strong Buy
  • CCSI Buy
  • Analyst Count
  • IMAB 6
  • CCSI 4
  • Target Price
  • IMAB $7.50
  • CCSI $28.75
  • AVG Volume (30 Days)
  • IMAB 2.2M
  • CCSI 102.3K
  • Earning Date
  • IMAB 11-14-2025
  • CCSI 11-05-2025
  • Dividend Yield
  • IMAB N/A
  • CCSI N/A
  • EPS Growth
  • IMAB N/A
  • CCSI N/A
  • EPS
  • IMAB N/A
  • CCSI 4.15
  • Revenue
  • IMAB N/A
  • CCSI $349,595,000.00
  • Revenue This Year
  • IMAB N/A
  • CCSI $1.55
  • Revenue Next Year
  • IMAB N/A
  • CCSI $1.10
  • P/E Ratio
  • IMAB N/A
  • CCSI $6.58
  • Revenue Growth
  • IMAB N/A
  • CCSI N/A
  • 52 Week Low
  • IMAB $0.60
  • CCSI $17.84
  • 52 Week High
  • IMAB $6.79
  • CCSI $32.10
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 49.60
  • CCSI 52.99
  • Support Level
  • IMAB $4.13
  • CCSI $25.25
  • Resistance Level
  • IMAB $6.79
  • CCSI $27.48
  • Average True Range (ATR)
  • IMAB 0.72
  • CCSI 0.93
  • MACD
  • IMAB -0.14
  • CCSI 0.04
  • Stochastic Oscillator
  • IMAB 21.43
  • CCSI 77.78

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: